Stock Comparison
AZN vs JNJ
AstraZeneca PLC and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$292.20B
$613.02B
P/E (TTM)
28.4
29.5
Forward P/E
17.9
22.0
Price/Sales
4.8
6.4
Price/Book
6.2
7.6
EV/EBITDA
15.8
19.2
Dividend Yield
1.72%
2.12%
Profitability
Net Margin
17.20%
21.80%
Operating Margin
27.90%
27.40%
Return on Equity
23.50%
26.40%
Return on Assets
8.49%
8.42%
Growth (YoY)
Revenue Growth
12.50%
9.90%
Earnings Growth
5.30%
-52.90%
Price & Risk
Beta
0.2
0.3
52-Week High
$210.50
$255.11
52-Week Low
$134.85
$147.81
Analyst Target
$224.49
$257.32
Compare AZN and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.